International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewRafaël Fonseca, Hervé Avet‐Loiseau, Antonino Neri et al.|Leukemia|2009Cited by 877
Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose ChemotherapyJohannes Drach, H. Huber, Jutta Ackermann et al.|Blood|1998Cited by 321
Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.Johannes Drach, R. Heinz, J. C. Schuster et al.|PubMed|1995Cited by 199
Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significanceJohannes Drach, Heinz Ludwig, J Angerler et al.|Blood|1995Cited by 140
Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.Martin Filipits, Robert Pirker, Johannes Drach et al.|PubMed|1999Cited by 44